Skip to main content

Peer Review reports

From: Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis

Original Submission
1 Mar 2021 Submitted Original manuscript
19 Mar 2021 Author responded Author comments - Sheila D Rustgi
Resubmission - Version 2
19 Mar 2021 Submitted Manuscript version 2
10 Apr 2021 Reviewed Reviewer Report
13 Apr 2021 Reviewed Reviewer Report
27 Apr 2021 Author responded Author comments - Sheila D Rustgi
Resubmission - Version 3
27 Apr 2021 Submitted Manuscript version 3
4 May 2021 Author responded Author comments - Sheila D Rustgi
Resubmission - Version 4
4 May 2021 Submitted Manuscript version 4
Publishing
5 May 2021 Editorially accepted
24 May 2021 Article published 10.1186/s12885-021-08306-5

You can find further information about peer review here.

Back to article page